Toledo, OH – According to filings with the U.S. Securities and Exchange Commission, Osteonovus is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Anand Agarwal played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Osteonovus

OsteoNovus is an early stage orthopaedic medical device company focused on the development of biologic materials to support and regenerate bone. The company’s innovative technology encompasses novel synthetic calcium phosphate based cements suitable for several clinical applications, including bone voids, treatment of various fractures and spinal disorders. The product is available in various forms such as putty (injectable and moldable), granules and structural blocks for orthopaedic and spine surgery.

To learn more about Osteonovus, visit http://www.osteonovus.com/

Contact:
Anand Agarwal, President and Chief Executive Officer
419-530-5940
https://www.linkedin.com/in/a-agarwal-md-86531531/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved